Literature DB >> 15246020

Is damage in central nervous system due to inflammation?

A Chavarria1, J Alcocer-Varela.   

Abstract

The aim of this work was to review the inflammatory factors involved in central nervous system (CNS) inflammation and the damage associated to their participation in an inflammatory disease of CNS, multiple sclerosis in humans and experimental allergic encephalomyelitis in the murine model. Inflammation has an important repairing function, nevertheless frequently in the CNS inflammation is the cause of damage and it does not fulfill this repairing function as it happens in other compartments of the body. The inflammatory response in the CNS involves the participation of different cellular types of the immune system (macrophages, mast cells, T and B lymphocytes, dendritic cells) and resident cells of the CNS (microglia, astrocytes, neurons), adhesion molecules, cytokines and chemokines among other proteic components. During neuroinflammation chemotaxis is an important event in the recruitment of cells to the CNS. The lymphocyte recruitment implies the presence of chemokines and chemokine receptors, the expression of adhesion molecules, the interaction between lymphocytes and the bloodbrain barrier (BBB) endothelium, and finally their passage through the BBB to arrive at the site of inflammation. If this process is not controlled, is prolonged, inflammation loses its repairing function and can be the cause of damage. Usually neuroinflammation has the tendency to decline to damage, which would explain most of the CNS pathologies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15246020     DOI: 10.1016/j.autrev.2003.09.006

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  30 in total

Review 1.  Function of Act1 in IL-17 family signaling and autoimmunity.

Authors:  Ling Wu; Jarod Zepp; Xiaoxia Li
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

2.  Building-associated neurological damage modeled in human cells: a mechanism of neurotoxic effects by exposure to mycotoxins in the indoor environment.

Authors:  Enusha Karunasena; Michael D Larrañaga; Jan S Simoni; David R Douglas; David C Straus
Journal:  Mycopathologia       Date:  2010-06-13       Impact factor: 2.574

3.  MAPK p38 regulates transcriptional activity of NF-kappaB in primary human astrocytes via acetylation of p65.

Authors:  Ramendra N Saha; Malabendu Jana; Kalipada Pahan
Journal:  J Immunol       Date:  2007-11-15       Impact factor: 5.422

4.  Expression and distribution of Toll-like receptors in the brain during murine neurocysticercosis.

Authors:  Bibhuti B Mishra; Pramod K Mishra; Judy M Teale
Journal:  J Neuroimmunol       Date:  2006-09-29       Impact factor: 3.478

5.  STAT6⁻/⁻ mice exhibit decreased cells with alternatively activated macrophage phenotypes and enhanced disease severity in murine neurocysticercosis.

Authors:  Bibhuti B Mishra; Uma Mahesh Gundra; Judy M Teale
Journal:  J Neuroimmunol       Date:  2010-11-03       Impact factor: 3.478

6.  Increased disease severity of parasite-infected TLR2-/- mice is correlated with decreased central nervous system inflammation and reduced numbers of cells with alternatively activated macrophage phenotypes in a murine model of neurocysticercosis.

Authors:  Uma Mahesh Gundra; Bibhuti B Mishra; Kondi Wong; Judy M Teale
Journal:  Infect Immun       Date:  2011-04-11       Impact factor: 3.441

Review 7.  Immunoglobulin-mediated neuro-cognitive impairment: new data and a comprehensive review.

Authors:  Assaf Menachem; Joab Chapman; Yael Deri; Chaim G Pick; Aviva Katzav
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

8.  MyD88-deficient mice exhibit decreased parasite-induced immune responses but reduced disease severity in a murine model of neurocysticercosis.

Authors:  Bibhuti B Mishra; Uma Mahesh Gundra; Kondi Wong; Judy M Teale
Journal:  Infect Immun       Date:  2009-09-28       Impact factor: 3.441

Review 9.  Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers.

Authors:  Fabien Chauveau; Hervé Boutin; Nadja Van Camp; Frédéric Dollé; Bertrand Tavitian
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-10-01       Impact factor: 9.236

10.  Variable effects of cyclophosphamide in rodent models of experimental allergic encephalomyelitis.

Authors:  K Mangano; A Nicoletti; F Patti; M Donia; L Malaguarnera; S Signorelli; G Magro; V Muzio; B Greco; P Zaratin; P Meroni; M Zappia; F Nicoletti
Journal:  Clin Exp Immunol       Date:  2009-11-18       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.